EUVIMEDEUVIMED entdecken
Crossref

Potential alternative dosage strategies for patent-protected oral cancer drugs

Austin Wesevich, Liam J Schmitt, Mark J Ratain

European Journal of Cancer · 2025

DOI: 10.1016/j.ejca.2025.116067 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2025. Verfasst von Austin Wesevich und 2 weiteren Autor:innen. Beteiligte Einrichtung: Section of Hematology/Oncology, University of Chicago, Chicago, IL, United States. Electronic address: austin.wesevich@uchicagomedicine.org. Hauptthemen laut MEDLINE: Patents as Topic, Antineoplastic Agents, Cost Savings, Drug Costs. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Arnold Ventures LLC, Laura and John Arnold Foundation, National Institutes of Health National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Patents as TopicAntineoplastic AgentsCost SavingsDrug CostsNeoplasmsAdministration, OralDose-Response Relationship, DrugUnited States Food and Drug AdministrationUnited StatesDrug ApprovalEuropeHumansMaximum Tolerated DoseRandomized Controlled Trials as TopicResearch Design

Stichwörter der Autor:innen

Clinical trial designDose optimizationOncology drugsPharmacoeconomicsQuality of life

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Section of Hematology/Oncology, University of Chicago, Chicago, IL, United States. Electronic address: austin.wesevich@uchicagomedicine.org.
  • Center for Personalized Therapeutics, University of Chicago, Chicago, IL, United States.
  • Section of Hematology/Oncology, University of Chicago, Chicago, IL, United States; Center for Personalized Therapeutics, University of Chicago, Chicago, IL, United States.

Förderung

  • Arnold Ventures LLC
  • Laura and John Arnold Foundation
  • National Institutes of Health National Cancer Institute

Zitieren

APA

Wesevich, A., Schmitt, L. J., & Ratain, M. J. (2025). Potential alternative dosage strategies for patent-protected oral cancer drugs. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2025.116067

Vancouver

Wesevich A, Schmitt LJ, Ratain MJ. Potential alternative dosage strategies for patent-protected oral cancer drugs. European Journal of Cancer. 2025. doi:10.1016/j.ejca.2025.116067

BibTeX
@article{Wesevich2025,
  author = {Wesevich, Austin and Schmitt, Liam J and Ratain, Mark J},
  title = {Potential alternative dosage strategies for patent-protected oral cancer drugs},
  journal = {European Journal of Cancer},
  year = {2025},
  doi = {10.1016/j.ejca.2025.116067}
}
Kostenlos starten →